Cancer is one of the most prevalent and deadly diseases in the United States today. There are many approaches to treating cancer, but here we focus on biochemotherapy which is a combination of chemotherapy and immunotherapy. The intent of immunotherapy is to boost the body’s natural resistance to cancer which is often repressed by the regulatory branch of the immune system. Here we show that this repression may be overcome by chemotherapy followed closely by immunotherapy. However, giving immunotherapy at the wrong time can may actually promote tumor growth.
| Identifer | oai:union.ndltd.org:CLAREMONT/oai:scholarship.claremont.edu:hmc_theses-1203 |
| Date | 01 May 2007 |
| Creators | Moore, James |
| Publisher | Scholarship @ Claremont |
| Source Sets | Claremont Colleges |
| Detected Language | English |
| Type | text |
| Format | application/pdf |
| Source | HMC Senior Theses |
Page generated in 0.0585 seconds